A. Aparicio

发表

Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry

E. Coto, P. Avanzas, S. Hevia, 2020, Journal of clinical medicine.

Premature STEMI in Men and Women: Current Clinical Features and Improvements in Management and Prognosis

P. Avanzas, R. Diaz, D. Hernández-Vaquero, 2021, Journal of clinical medicine.

Slow Coronary Blood Flow: Pathogenesis and Clinical Implications

J. Cuevas, C. Morís, María Martín, 2022, European cardiology.

Ischaemic Heart Disease

J. Cuevas, C. Morís, María Martín, 2022 .

Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

E. Coto, C. Martínez-Faedo, Lorena Suárez-Gutiérrez, 2023, Journal of clinical medicine.

Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

E. Coto, P. Avanzas, I. Pascual, 2023, Journal of clinical medicine.

Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome

E. Coto, P. Avanzas, I. Pascual, 2020, Journal of clinical medicine.

Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

E. Coto, P. Avanzas, I. Pascual, 2023, Journal of clinical medicine.

Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

E. Coto, P. Avanzas, I. Pascual, 2023, Journal of clinical medicine.

PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal.

Daniel Vázquez-Coto, A. Aparicio, Claudia García-Lago, 2024, International Journal of Cardiology.